Weight Loss, GLP-1 Injections, Branded Medications

Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply — Complete Product Information & Specifications

FDA-approved Wegovy® (semaglutide) once-weekly subcutaneous autoinjector pen for chronic weight management and cardiovascular risk reduction in eligible adults.

Product overview

Wegovy® (semaglutide) is an FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity. In landmark STEP clinical trials, adults treated with once-weekly Wegovy 2.4 mg achieved an average body weight reduction of 14.9% over 68 weeks.

By selectively binding to and activating GLP-1 receptors in the hypothalamus and gastrointestinal tract, Wegovy slows gastric emptying, enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, and significantly reduces appetite and food noise. Treatment follows a structured 5-step monthly dose escalation (0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg weekly) to optimize gastrointestinal tolerability.

Through Join Amble Health, patients complete a streamlined online medical intake reviewed by a licensed healthcare provider. When clinically appropriate, your prescription or wellness protocol is fulfilled by a vetted partner pharmacy and shipped directly to your door with clear administration instructions, dosing schedules, and ongoing clinical support.

Product specifications

Product Name	Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply
SKU	AMB-WEGOVY-PEN
Category	Weight Loss, GLP-1 Injections, Branded Medications
Active Ingredients & Strength	Semaglutide (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg per 0.5 mL / 0.75 mL single-dose pen)
Dosage Form & Schedule	FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) — Inject once weekly on the same day each week, with or without food
Price	$1,349.00
Availability	In stock (Provider Evaluation Required)

Product features

Genuine Novo Nordisk FDA-approved single-dose pre-filled autoinjector pens (4 pens per 28-day carton).
Clinically proven 14.9% average body weight reduction and FDA-indicated cardiovascular risk reduction.
Hidden-needle push-button autoinjector design requiring no manual vial drawing or reconstitution.
Structured specification table and transparent monthly program pricing with no hidden membership fees.
Direct pharmacy fulfillment with lot traceability, patient administration guides, and provider messaging access.

Quality and documentation

Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply is an FDA-approved prescription brand medication dispensed in original manufacturer-sealed single-dose or multi-dose autoinjector pens through licensed U.S. partner pharmacies after a complete medical evaluation by a licensed healthcare provider.

Every order is accompanied by pharmacy-issued labeling detailing the active ingredient concentrations, beyond-use date (BUD) or manufacturer expiration date, lot number, and step-by-step patient administration instructions. Patients should verify the package seal and storage instructions immediately upon delivery.

Storage and handling

Refrigerate between 36°F to 46°F (2°C to 8°C) in original carton to protect from light. Do not freeze.

Always keep medications and bioactive peptides out of reach of children and pets. Do not use any product past the printed expiration or beyond-use date on the pharmacy label, and never share prescription medications with another person.

Important product information

Product descriptions on Join Amble Health are provided for educational and catalog transparency purposes and do not replace individualized medical advice, diagnosis, or treatment from a licensed clinician. Eligibility for prescription weight management, hormone optimization, peptide therapy, or dermatological treatment is determined solely by your evaluating healthcare provider based on your medical history, current medications, contraindications, and laboratory findings where required.

Price, delivery and purchase terms

Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply is listed at $1,349.00 in the Amble Health Shop under Weight Loss, GLP-1 Injections, Branded Medications. Temperature-sensitive injectable and biological formulations are shipped via expedited insulated cold-chain carrier, while room-temperature oral, sublingual, nasal, and topical formulations ship in discreet protective packaging with full tracking.

Frequently asked questions

What is included with Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply?

Each 4-week supply of Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply (AMB-WEGOVY-PEN) includes the prescribed formulation (Semaglutide (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg per 0.5 mL / 0.75 mL single-dose pen) in FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) format), complete pharmacy labeling, administration supplies if applicable, and ongoing asynchronous clinical support through your Amble patient portal.

How is Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply administered?

Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply is formulated as a FDA-Approved Single-Dose Subcutaneous Autoinjector Pen (Box of 4 Pens) and is typically used according to the following schedule: Inject once weekly on the same day each week, with or without food. Your prescribing clinician will provide personalized dosing and titration instructions tailored to your clinical goals and tolerance.

Do I need a prescription or medical consultation for Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply?

Yes. After selecting your treatment plan, you will complete a comprehensive online health intake. A licensed healthcare provider in your state reviews your medical history, contraindications, and treatment goals before issuing a prescription to our partner pharmacy.

How should I store Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply once it arrives?

Refrigerate between 36°F to 46°F (2°C to 8°C) in original carton to protect from light. Do not freeze. Always inspect the pharmacy label upon arrival and follow the specific storage temperature and light-protection guidelines printed on your container.

Can Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply be combined with other Amble Health protocols?

Many patients pair metabolic, longevity, or dermatological protocols under clinician supervision—such as combining GLP-1 therapy with NAD+ cellular support or gastro-protective B6/B12 co-factors. Disclose all current medications and supplements during intake so your provider can verify compatibility.

Where can I review pricing and shipping updates?

Current pricing ($1,349.00), stock status, and delivery terms are displayed directly on this product page and in your checkout summary prior to order confirmation.

Product and regulatory references

US online ordering information

Information for customers reviewing Wegovy Semaglutide Pen online from the United States.

A catalog listing or an enabled Add to cart button is not clinical approval or confirmation of lawful dispensing. Before ordering, confirm the exact formulation, strength, quantity, required prescription review, dispensing pharmacy and eligibility in your state. No nationwide prescribing or fulfillment coverage is implied.

Use the live price and stock display on this page and review the final checkout total. Delivery, tax and return conditions depend on the product and destination; do not assume a delivery date or eligibility from this page alone.

For product or ordering questions, email hello@joinamblehealth.com. Read the Amble terms of service or visit your Amble account.

Branded GLP-1

Wegovy® (Semaglutide) Branded Autoinjector Pen — 4-Week Supply